優先晶出法を利用したジヒドロ-1,3,5トリアジンラセミ体のエナンチオマー分離のための方法

Title:

優先晶出法を利用したジヒドロ-1,3,5トリアジンラセミ体のエナンチオマー分離のための方法

Document Type and Number:

Japanese Patent JP5536869

Kind Code:

B2

Abstract:

A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.

More Like This:

JP2009523140	Use of triazine derivatives for the manufacture of pharmaceuticals with scarring or angioplasting effects
WO/2003/074498	CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT
WO/2007/116314	N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES

Inventors:

Helm Reich, Matthias
Nizart, Klaus-Peter
Clavo, Daniel
Coquerel, gerard
Guillaume
Washarenes-Antal, Sao Sen
Cardinal, pascal

Application Number:

JP2012501317A

Publication Date:

July 02, 2014

Filing Date:

March 26, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

POXEL SAS

International Classes:

C07D251/10; A61K31/53; A61P3/10; C07B57/00; C07B63/00; C07C53/122

Domestic Patent References:

JP59065075A
JP2006263567A
JP9506861A
JP2006522753A
JP2011529469A

Foreign References:

WO2008126831A1

Attorney, Agent or Firm:

Hajime Tsukuni
Satoko Ito
Keiko Ozawa

Previous Patent: JPS5536868

Next Patent: PARTIALLY COLORING TWO COLOR ELECTROPHOTOGRAPHY